Summary
- Current Price
- As of today, NKTR price is $84.16, down -3.14% on
- Current Price All-Time High
- NKTR price is currently -94.96% below its historical high of $1,670.40 set on
- Market Cap
- NKTR current market cap is $3B, up +2284.21% over the past 365 days
- PE Ratio
- NKTR PE ratio is unknown
- Revenue
- NKTR current annual revenue is $55.23M, down -43.89% year-over-year
- Next Earnings
- The next earnings release for NKTR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nektar Therapeutics |
| Ticker | NASDAQ: NKTR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nektar.com |
| Employees | 61 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $84.16 | |
| Price, 1D Change | -3.14% | |
| $3B | ||
| - | ||
| - | ||
| 3.12 | ||
| $55M | ||
| Revenue, 1Y Change | -43.89% | |
| -$9.73 | ||
| EPS, 1Y Change | -12.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$9.73 | ||
| EPS Estimate | N/A | -$8.54 |
| EPS Est. Change | N/A | +12.24% |
| $55.23M | ||
| Revenue Estimate | N/A | $41.52M |
| Revenue Est. Change | N/A | -24.82% |
| Current Price | $84.16 | |
| Price Target | - | $150.00 |
| Price Tgt. Change | - | +78.23% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.80 | -$8.68 | -984.56% | |
| -$9.37 | -$9.73 | -3.79% | |
| -$8.54 | N/A | +12.24% | |
| -$10.79 | N/A | -10.92% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $105.92M | $98.43M | -7.08% | |
| $43.78M | $55.23M | +26.15% | |
| $41.52M | N/A | -24.82% | |
| $35.92M | N/A | -34.97% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $84.16 | |
| $54.37 | ||
| SMA 200 vs Price | -35.40% | |
| $77.30 | ||
| SMA 50 vs Price | -8.15% | |
| 3.12 | ||
| $5.26 | ||
| 52.03 | ||
| 43.16% | ||
| 187.93% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $55.23M | ||
| -$9.73 | ||
| $55.23M | ||
| 98.14% | ||
| -$130.77M | ||
| -236.77% | ||
| -$164.08M | ||
| -297.07% | ||
| -$133.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.66 | ||
| 4.97 | ||
| 4.97 | ||
| - | ||
| 3 | ||
| -10.27 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 51.41 | ||
| 31.61 | ||
| -21.14 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $89.83M | ||
| $245.75M | ||
| $280.41M | ||
| $266.27M | ||
| $190.57M | ||
| $53.54M | ||
| $148.91M | ||
| $20.50M | ||
| $10.77M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $219.31M | ||
| $186.00M | ||
| $1.03M | ||
| $0.00 | ||
| $1.03M | ||
| $0.00 | ||
| -$138.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$208.51M | ||
| -$1.20M | ||
| $180.57M | ||
| $171.00K | ||
| -$208.68M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Wedbush | ||
| TD Cowen | ||
| Citigroup | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with NKTR
FAQ
What is the ticker symbol for Nektar Therapeutics?
The ticker symbol for Nektar Therapeutics is NASDAQ:NKTR
Does Nektar Therapeutics pay dividends?
No, Nektar Therapeutics does not pay dividends
What sector is Nektar Therapeutics in?
Nektar Therapeutics is in the Healthcare sector
What industry is Nektar Therapeutics in?
Nektar Therapeutics is in the Biotechnology industry
What country is Nektar Therapeutics based in?
Nektar Therapeutics is headquartered in United States
When did Nektar Therapeutics go public?
Nektar Therapeutics initial public offering (IPO) was on May 3, 1994
Is Nektar Therapeutics in the S&P 500?
No, Nektar Therapeutics is not included in the S&P 500 index
Is Nektar Therapeutics in the NASDAQ 100?
No, Nektar Therapeutics is not included in the NASDAQ 100 index
Is Nektar Therapeutics in the Dow Jones?
No, Nektar Therapeutics is not included in the Dow Jones index
When was Nektar Therapeutics last earnings report?
Nektar Therapeutics's most recent earnings report was on November 6, 2025
When does Nektar Therapeutics report earnings?
The next expected earnings date for Nektar Therapeutics is May 7, 2026
Data Sources & References
- NKTR Official Website www.nektar.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm
- NKTR Profile on Yahoo Finance finance.yahoo.com/quote/NKTR
- NKTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nktr